Lenvatinib (E7080) Powder Briefing
Lenvatinib is an oral, multitarget tyrosine kinase inhibitor that inhibits VEGFR2(KDR) and VEGFR3(FLT-4) with IC50 of 4 and 5.2 nM, respectively.
What is LENVIMA?
LENVIMA (lenvatinib) is a prescription medicine that is used to treat people with certain kinds of cancer.
- LENVIMA is used by itself to treat differentiated thyroid cancer (DTC), a type of thyroid cancer that can no longer be treated with radioactive iodine and is progressing.
- LENVIMA is used along with another medicine called everolimus to treat adults with a type of kidney cancer called advanced renal cell carcinoma (RCC) after one course of treatment with another anti-cancer medicine.
- LENVIMA is used by itself as the first treatment for a type of liver cancer called hepatocellular carcinoma (HCC) when it cannot be removed by surgery.
How to process the order?
- send us an email toinfo@bulkrawspharma.com with the following details: product names, quantity and your special requests (eg. need custom produced)
- we quote and confirm your request details
- we ship your order after payment done and offer tracking code & packing pictures within 1-3 days
- we will keep you updated of your order status
- order received and review our services
Payment terms
MoneyGram, Western Union, Bitcoin,T/T Bank transfer,USDT.escrow alibaba (credit card,paypal),etc.
Reviews
There are no reviews yet.